Podcasts about Deprescribing

Cassels shares how patients can ask smarter questions, avoid unnecessary meds, and regain control in the exam room. #PatientAdvocacy #AskYourDoctor #InformedDecisions #HealthTalks

In Deutschland leben rund 800.000 Pflegebewohner – chronisch erkrankt, multimorbid und angewiesen auf gut koordinierte ärztliche Versorgung. Die Realität sieht jedoch oft ganz anders aus. Hausärzte sind überlastet, Pflegekräfte fehlen, und die Kommunikation zwischen Arztpraxis und Heim funktioniert häufig nicht. Wenn Pflegekräfte anrufen, erreichen sie niemanden. Wenn Ärzte zurückrufen, finden sie keine Ansprechpartner vor Ort. Manchmal dauert es Tage, bis eine ärztliche Reaktion möglich ist. Dr. Irmgard Landgraf, Hausärztin in Berlin-Steglitz, hat dieses Problem für sich gelöst – durch digitale Pflegeheimakten. Seit mehr als 20 Jahren versorgt sie Patienten in Pflegeeinrichtungen und hat wissenschaftlich belegt, wie digitale Vernetzung die Versorgung revolutioniert. Mit ihrem Ansatz sind kürzere Reaktionszeiten möglich, die Patientenergebnisse verbessern sich, Krankenhausaufenthalte nehmen ab, es entstehen erhebliche Kosteneinsparungen – und vor allem profitiert das Pflegepersonal von einer massiven Entlastung. In dieser Folge sprechen wir mit Dr. Landgraf über die Entwicklung der Heimversorgung über drei Jahrzehnte hinweg und beleuchten die spezifischen Herausforderungen, die entstehen, wenn ältere, multimorbide Patienten mit komplexen Medikationsplänen versorgt werden müssen. Wir analysieren das klassische Kommunikationsproblem zwischen Praxis und Heim sowie seine gravierenden Folgen und stellen die digitale Pflegeheimakte als praktischen Lösungsansatz vor – als Möglichkeit des asynchronen Informationsaustauschs, der endlose Telefonmarathons überflüssig macht. Ein weiteres Thema ist auch die Arzneimittelsicherheit: Wie weniger oft mehr ist und wie gezieltes Deprescribing die Polymedikation sinnvoll reduziert. Dr. Landgraf erklärt zudem die unverzichtbare Rolle des Pflegepersonals als „Augen und Ohren" des Arztes und gibt praktische Tipps zur Zeitplanung von Heimbesuchen. Abschließend berichten wir über das Baden-Württemberg-Innovationsfonds-Projekt, seine Ergebnisse und Erfolgszahlen, und diskutieren, warum gute Versorgungsmodelle nicht automatisch zur Regelversorgung werden – sowie die Chancen und Herausforderungen der Digitalisierung im deutschen Gesundheitswesen. Diese Folge ist für Hausärzte, Allgemeinmediziner und Ärzte mit Heimversorgung gedacht ebenso wie für Praxismanager, Pflegeheimleiter, Pflegekräfte und Gesundheitspolitiker – kurz: für alle, die sich leidenschaftlich für eine bessere Versorgung älterer Menschen einsetzen. https://bit.ly/4hoYfbK

Hosts: Ed Jones (Owner of Nutrition World) & Clint Powell A variety of topics all to living a healthy life Presented by: Nutrition World www.nutritionw.com Broadcasting from the Nooga Dentistry Studio www.noogadentistry.com Production of: Whitfield Media Group www.vitalhealthradio.com Title: All about Eggs & Pasture Raised Chickens with Kristy, Deprescribing & “De-Supplementing” with Dr. Curt Dearing [0:00:00] Intro, Nutrition World Updates, and Ed's Bodybuilding Prep Ed announces a new partnership with Azure: Bringing ~100 new holistic food items into Nutrition World. Examples: maple syrup, coconut oil, apple cider vinegar, organic chicken breast, cheeses, farm butters. Ed shares he's preparing for the Chattanooga Fitness Bodybuilding Contest (his 4th year): Being coached by Matt Davis (Train Station gym). Current approach: high protein, ~40% fewer calories, focused fat loss. Matt had him do a high-carb refeed day (~300g carbs vs his usual 50g) which dramatically improved his energy and look. [0:9:11] Protein, Longevity, and Why Ed Focuses on Eggs Ed emphasizes a higher-protein diet, especially for aging, muscle maintenance, and longevity. Core diet elements he advocates: Higher protein Healthy fats Colorful vegetables (in smaller but consistent amounts) Notes many women under-consume protein, which accelerates muscle loss and impacts longevity. Introduces guest Kristy, a long-time friend and staff member who homesteads and raises eggs that Ed eats 12–18 per week. [0:11:04] Homesteading with Kristy: How She Raises Chickens and Protects the Flock Kristy's setup: Around 100 chickens, plus goats, dogs, cats, and a donkey (Bradford). Lives “on the prairie” (rural, wooded property). Uses no chemicals on the property (no weed killers, pest sprays, etc.). She wants chickens to “do chicken things”—roam, peck, eat bugs, move soil—rather than be treated like pets or indoor animals. Predator control: No perimeter fence; previously lost some chickens to a fox attack. Now uses Bradford the donkey and a Great Pyrenees dog for protection: Donkey alerts and deters daytime predators like hawks and owls (stomping and loud calls). Pyrenees patrols at night, primarily deterring coyotes. Roosters herd hens into cover when threats appear. Motivator: Kristy's passion for knowing where her food comes from, and controlling at least part of her family's food system. [0:15:09] Structured Water, and Animal Hydration Kristy filters all animal water with a high-grade system (not just a basic fridge filter): Removes contaminants without completely stripping all minerals (not full RO). Then she “restructures” the water with a swirling device (structure unit): Mimics water flowing over rocks in nature, believed to add “life” and energy back to the water. She and Ed both report feeling better hydration from structured water (less persistent thirst). All of her animals receive this filtered/structured water. [0:17:26] Egg Production, Breeds, and Why Yolk Color Matters Kristy keeps multiple chicken breeds: Shell color = breed, not nutrition (white, brown, cream, etc., are just different breeds). Example: White Leghorn → white eggs, Rhode Island Red → darker brown eggs. Key nutritional indicator: yolk color She aims for deep orange yolks. Pale yellow yolks signal lower nutrient density, especially protein and nutrient intake from the chickens' diet. Production basics: Most hens lay about 5–6 eggs per week, especially in their first 3 years. Ed and Clint estimate she's getting hundreds of eggs per week in total. Kristy's flock policy: She has a “no-kill” policy for older hens, keeping them for tick and bug control and the social flock structure. Acknowledges some people cull flocks after 2–3 years, but she tends to keep productive, healthy hens past 4 years. [0:19:37] Industrial Eggs vs. Pasture-Raised: Animal Welfare and Nutrition Ed contrasts Kristy's setup with CAFO operations (Concentrated Animal Feeding Operations): Chickens crowded in small cages, poor conditions, bad feed. Notes such operations often use antibiotics—partly for disease, but also because they fatten animals. Kristy's holistic management: No antibiotics; uses natural anti-parasite and immune support: Pumpkin seeds for worms Homegrown herbs like oregano and rosemary She builds a strong “terrain” (internal environment) in the animals so they resist disease better. Discussion that what chickens eat (seed oils, moldy grains, etc. in industrial systems) ultimately affects the nutritional quality of the eggs humans eat. Nutritional highlights of eggs: Choline in yolks (brain and cognitive health). A “perfect protein” with high biological value and broad micronutrients. Eggs historically rank at the top for turning dietary protein into muscle due to a complete amino acid profile. Cholesterol discussion: Ed challenges the blanket fear of cholesterol: Cholesterol supports hormone production and brain function. Notes that the real risk markers are advanced lipoproteins like ApoB and Lp(a), not total cholesterol alone. Personal example: Ed eats 12–18 eggs per week. & his cholesterol is extremely low by clinical standards. Conclusion: Quality eggs are encouraged, especially from pasture-based systems like Kristy's, or higher-quality options in stores. [0:23:15] “Organic” vs. “Pasture-Raised” and Misleading Egg Labels “Organic eggs”: fed organic feed but may still be confined indoors with no outdoor access. “Pasture-raised”: hens are outdoors on pasture, doing natural chicken behaviors; often superior in welfare and nutrition. Both agree: If forced to choose, pasture-raised is preferable to organic-only. They call out labels bragging about “vegetarian-fed” hens as misleading: Chickens are not natural vegetarians; they're omnivores that eat bugs. Forcing a vegetarian diet moves them away from their natural food and may reduce egg quality. Kristy shares a quirky but natural behavior: Chickens love scrambled eggs as a treat. She feeds them scrambled eggs and crushed shells. Rationale: Eggshells are rich in calcium, which hens need to build strong new shells. She simply cracks and throws shells; no elaborate processing.. [0:27:25] Refrigeration vs. Room-Temperature Egg Storage Kristy's explanation: Freshly laid eggs have a “bloom” or natural protective coating that makes them shelf-stable if not washed. Unwashed farm eggs can sit at room temperature for ~6 weeks or more. Store-bought eggs are washed and must be refrigerated, because washing removes that protective coating. You cannot safely leave standard grocery-store eggs on the counter. Ed highlights this as another example of nature's built-in protective design. [0:32:28] Deprescribing and “De-Supplementing” with Dr. Curt Dearing Ed reintroduces Dr. Curt Dearing to expand on a prior show about deprescribing (reducing excessive medications). Common scenario Curt sees: People on many prescription meds plus a large number of supplements, overwhelmed and confused. They want to simplify, optimize, and know what really matters. Curt's consult approach: Review all meds and all supplements, then: Remove what isn't necessary. Emphasize foundational lifestyle and core supplements. They warn about a false sense of security: Some people think “I'm taking a pill, so I don't have to change my habits.” This applies to both pharmaceuticals and nutraceuticals. [0:36:00] The Core Four, Lifestyle First, and Limits of Medication-Only Approaches Ed references his “Core Four” foundational supplements (detailed in a free ebook on The Holistic Navigator): Designed as tier 1 essentials vs. lower-tier “nice-to-have” supplements. Curt's stance: Diet and exercise are the primary pillars. Supplements should support, not replace, healthy habits. Example: People on metformin or berberine may keep eating poorly yet feel “covered” because their blood sugar numbers look better. This is managing symptoms, not addressing root causes. [37:15] “Beyond Cholesterol” and Advanced Heart Risk Testing Curt mentions his upcoming ebook “Beyond Cholesterol” (targeting Amazon release): Argues standard lipid panels (total cholesterol, LDL, HDL) are not enough. Advocates for advanced tests like ApoB, Lp(a), and coronary calcium scores. Example case: A patient with LDL of 212 on atorvastatin. Curt notes that LDL alone can be “dangerous or harmless” depending on the underlying particle types and inflammation. Coronary Calcium Score: Patient's score is 0, which is reassuring but not a free pass. Calcium score detects calcified plaque, not soft plaque, and doesn't capture inflammation. Curt emphasizes HS-CRP (high-sensitivity C-reactive protein) as a marker of systemic inflammation, which drives soft plaque formation. [0:40:22] Medications in the Case Study: Statin, Nexium, Amlodipine, Zoloft Curt walks through a specific patient on multiple meds: Atorvastatin (statin) Curt questions its necessity given: Calcium score of 0 Lipid values that don't look catastrophic Recommends advanced lipid testing and provides patients with evidence-based reasons to discuss with their provider if they want to stop. Nexium (PPI) Discusses risks of long-term proton pump inhibitor use: Impaired absorption of magnesium, calcium, micronutrients Possible cognitive, kidney, and bone issues. Insists on a taper, not cold turkey, due to rebound reflux. Amlodipine (blood pressure med) Often can be tapered fairly quickly, especially when: Lifestyle changes are implemented (diet, exercise). Magnesium intake is optimized (many people take too little magnesium). Curt's view: conventional medicine often drives blood pressure too low in older adults; some elevation is physiologically adaptive. Zoloft (SSRI) Must be tapered, like most psychiatric meds, to avoid withdrawal and symptom flare. [0:46:10] Magnesium, Omega-3s, and Simplifying the Supplement Stack Curt reviews the patient's supplement list and simplifies: Multivitamin: Advocates a high-quality multi (not basic synthetics like Centrum). Prefers one that already includes CoQ10 (e.g., 100 mg), so separate CoQ10 can be discontinued. Vitamin D: Should be taken with vitamin K to direct calcium into bone and away from arteries and organs. Omega-3s: Many people take half the necessary dose. Recommends triglyceride-form omega-3s like DHA Extra (~960 mg DHA) for inflammation and blood pressure. Magnesium: Suggests glycinate or taurate forms for better absorption and blood pressure benefits. Probiotics: Curt suggests taking breaks (e.g., a month off) and rotating brands/strains, including spore-based types. Seasonal products: The patient takes quercetin + stinging nettle for allergies. Curt recommends seasonal use only for seasonal allergies, saving money and reducing pill fatigue. For lipids and blood sugar, Curt favors BerberCol (berberine + bergamot) to: Improve numbers (to satisfy doctors). More meaningfully affect ApoB and related risk markers. Weight & energy: Patient had been using weight-loss products. Curt shifts focus to fixing sleep and overall lifestyle rather than stacking more “fat burners.” Saffron: He distinguishes between saffron extracts for mood vs. saffron for weight management—formulation details matter. [0:54:57] Closing: Funding for Alternative Health and Supplement Tax Benefits Ed shares policy/legislative updates: Alternative health funding preserved in the federal budget. Initial fear that support would be cut; instead, it was kept in the proposed budget. The Dietary Supplement Access Act proposal: Would classify dietary supplements as a qualified medical expense in the IRS code. Allow individuals to claim up to $500/year (and $250 for married filing separately) for supplements. Could apply to common products like multivitamins, vitamin D, etc. if/when finalized.  The post Radio Show / Podcast – June 14, 2026 first appeared on Vital Health Radio.

Adverse drug events cause 5-15% of admissions to hospital and drug-drug interactions make up about a fifth of these. Most common are pharmacodynamic situations where two drugs have a similar outcome thereby overdoing the intended outcome. Pharmacokinetic interactions are more complicated to understand as they're more indirect. For example, while medications are cleared by oxidative metabolism in the liver and gut, there are many drugs that interfere with the function of the cytochrome enzymes responsible. This can result in clearance of the first drug at too fast or too slow a rate.Polypharmacy has become more frequent over the decades with more than half of people over the age of 75 on five or more prescriptions. This episode examines some of the systems that have led to current rates of polypharmacy, and strategies for deprescribing safely in a given patient. We're REWINDing it nine years after it was first published to celebrate the career of Professor Ric Day who has just retired after sixty years of service at St Vincent's Hospital, Sydney. He has been a much-appreciated clinician and prolific research academic with several hundred published papers that have been cited more than forty thousand times.Chapters0:50 Prevalence of drug interactions5:52 Pharmacodynamic vs pharmacokinetic interactions 9:25 Cytochrome enzymes17:33 ACE inhibitors and more26:48 Strategies for deprescribingGuests Professor Richard Day AM MBBS, FRACP (St Vincent's Hospital; UNSW),Professor Sarah Hilmer AM PhD FRACP FAAHMS (Royal North Shore Hospital; Kolling Institute/ USyd). ProductionProduced by Mic Cavazzini DPhil. Music courtesy of FreeMusicArchive includes ‘Flying Pea' and ‘Cherry Blossom' by Daddy Scrabble and “Manly Nunn Steps Out” by Doctor Turtle. Music licenced from Epidemic Sound includes ‘Train Ride' (Instrumental) by Alex Kehm and ‘Yellow Leaf' by Autohacker. Image adapted for RACPAdd educational activity to MyCPD as educational activity or visit web page for a transcript and references.Key ReferencesLife-threatening drug interactions: what the physician needs to know [Internal Medicine Journal] Polypharmacy in older people: when should you deprescribe? [Medicine Today]

Deprescribing thyroid and other meds in older adultsCan I safely take serrapeptase for longer than four weeks?I want to take nattokinase but isn't there a 'clot dislodging' risk?Could you discuss C. difficile and how to treat it?

AI founders call for Congress to set guardrails against AI-accelerated bioweapon development; Deprescribing thyroid medication in seniors; Low-arginine/high lysine diets vs. herpes; Researchers test the “5 second rule” for dropped food; Long-term antidepressant use comes under new scrutiny.

Hosts: Ed Jones (Owner of Nutrition World) & Clint Powell A variety of topics all related to living a healthy life Presented by: Nutrition World www.nutritionw.com Broadcasting from the Nooga Dentistry Studio www.noogadentistry.com Production of: Whitfield Media Group www.vitalhealthradio.com Title: Impact of Tennessee Hemp Bill, Discussion of Polypharmacy & Deprescribing  with Dr. Curt Dearing [0:00:00] Ed's Media & Product Updates Preview of main topics: Upcoming Tennessee hemp bill and its negative impact on people using hemp for anxiety, pain, and insomnia. Dr. Curt Deering will discuss polypharmacy and deprescribing. Ed's recent appearances on multiple TV outlets (Fox Phoenix & LA, Be Well NY, CBS Detroit). Discussion of testing the AquaTru water filtration system at home as a potential recommendation (microplastics, partial fluoride removal). Mention that peptides are a growing topic; reference to Noel Lawson as go‑to for prescribed peptides [0:10:42]  Tennessee Hemp Bill & Hemp Industry Impact Introduces guest: Dwayne Madden, owner of Hemp House, as a respected local expert. As of July 1 in Tennessee: All Delta‑8 products will no longer be available for in‑state sale. Many THCA products and all vape products will be gone from shops. CBD and Delta‑9 edibles will have caps: Max 15 mg per serving. Max 300 mg per package. Dwayne notes: Heavy users (e.g., serious pain/conditions) will need to consume many servings to reach effective doses. Law doesn't limit how many packages a person can buy, so total milligrams aren't truly stopped—just made inconvenient. Dwayne explains regulatory control moved: From Tennessee Department of Agriculture (2017–2023) To the ABC (Alcoholic Beverage Commission) Board. Key impacts: All products must now go through distributors, similar to alcohol. Distributors collect taxes and sit between producers and retailers. Small operators like Dwayne cannot qualify for distributor licenses , so he must pay a distributor to move product from his own lab to his own stores. Ed frames this as “follow the money trail” and a way to crush competition. In Tennessee after July 1: No in‑state online hemp sales. Banned products (Delta‑8, etc.) not criminalized for possession or use, only for sale. Potential Workaround: Consumers can order from out‑of‑state websites (e.g., North Carolina), receive products in Tennessee Money leaves the local economy, hurting Tennessee businesses. Ed and Dwayne suggest alcohol industry is likely threatened because many people are reducing alcohol use by using hemp products instead  Dwayne notes: Alcohol sales have declined while hemp sales rose. Regulators appear to be protecting alcohol interests via hemp restrictions. [0:17:41] Federal Regulations & State Opt‑Outs Upcoming federal regulations in November: Expected to be similarly “ugly and nasty” for hemp nationwide. States will have an option to opt out of these federal hemp rules. Tennessee's stance: Governor has stated Tennessee will NOT opt out, so federal restrictions will apply here. Other states (e.g., North Carolina) might opt out, keeping their markets more open. Industry response: Advocacy groups Tennessee Growers Coalition and Hemp Law Group monitor legislation and organize pushback. Some supportive legislators exist, but political drive to reverse current law is limited. Dwayne and Ed distinguish: Reasonable regulation (ID checks, lab tests, dosage clarity, education) vs. A “wipeout/control/takeover” by shifting to ABC and forcing distributor reliance. Dwayne: Says credible local shops (Hemp House, Chattanooga peers like BeeGrity, Snapdragon, etc.) already follow high standards. States this law is not about safety but about control and revenue capture, and will hurt small farmers and businesses. [0:25:55] What Consumers Should Do Before Deadline Practical advice: Stock up now on products that will disappear: Delta‑8 gummies (popular for sleep, anxiety, pain). Other higher‑milligram THC/CBD edibles. Flower and vapes. Hemp House is running clearance sales to move remaining inventory. Dosing notes: Many people do well with ½ Delta‑8 gummy for sleep/anxiety/pain. Some need more or less; staff helps tailor doses for goals. Hemp House will close its North Shore/Tremont Street flagship store by July 1 due to expected sales hit. Remaining Hemp House locations: Ringgold Road (East Ridge) near Spring Creek. Ooltewah by Food City on Lee Highway. Hixson Pike near Workout Anytime and Publix. Broader impact: Other Chattanooga hemp businesses have large staffs (some near 100 employees) and will be heavily affected. The industry is described as grassroots, farmer‑driven, and passionately quality‑focused. [0:33:20] Polypharmacy & Deprescribing with Dr. Curt Dearing Ed introduces Dr. Curt Dearing, clinical pharmacist at Nutrition World (30+ years experience). Curt's background: Formerly fully conventional pharmacist; later “veil lifted” as he discovered green pharmacy (nutritional & botanical alternatives). Current mission: Community outreach to medical schools and residency programs Teach about nutritional and natural alternatives not covered in standard curriculums. Traditional training provides almost zero meaningful nutrition or green pharmacy education. Polypharmacy: use of 5 or more prescription medications. Curt notes: Majority of Americans 65+ meet this definition. Average American receives ~17 prescriptions per year (not all concurrent). Consequences: Increased ER visits due to drug side effects. Estimated ~250,000 deaths/year from drug‑induced causes. Curt's role: Specializes in deprescribing: safely reducing or eliminating unnecessary pharmaceuticals and replacing them with effective natural options when possible.  How Curt Works with Patients & Their Doctors Curt provides coaching, not independent prescribing. Creates detailed packets (10–18+ pages) explaining: Why certain drugs may no longer be needed. Evidence for natural alternatives (e.g., supplements, lifestyle changes). Encourages clients to take the packet to their doctor and have an informed discussion. Patients often fear how their doctors will react to attempts to deprescribe. Green Pharmacy Approach (as described by Dr. Curt Dearing) Using nutritional, botanical, and lifestyle-based therapies either instead of or alongside pharmaceuticals. Focusing on root causes and supporting the body's own healing mechanisms, not just pushing lab numbers in a certain direction. Why polypharmacy is a problem: Increases side effects, drug–drug interactions, and emergency room visits. Contributes to cognitive decline, gut problems, and overall worse health. Often leads to the “prescribing cascade”: Drug A causes side effects → a new drug is added for those side effects → more side effects → more drugs, and so on. How Dr. Curt Dearing uses green pharmacy to reduce polypharmacy: Curt creates a comprehensive list of all medications and supplements. Asks: “Why was this started?” and “Is it still needed?” Looks for: Drugs with no clear current indication. Drugs where a natural option can give similar or better benefit with fewer risks. Drugs that can be safely tapered or sometimes stopped outright (always in coordination with the prescriber). Identifies which meds are likely causing the most harm or least benefit. Some drugs require slow, structured tapering (e.g., sleep meds, acid blockers). Others may be candidates for direct discontinuation after medical agreement. Replacing or supporting with natural alternatives ( please note this is not medical advice, this is a discussion of personal examples in collaboration with medical oversight) Cholesterol: Instead of (or in place of some) statin use, Curt uses berberine and bergamot (Berbercol). In Ed's brother's case, his cholesterol numbers improved on green-pharmacy options, matching or exceeding statin outcomes without the same side‑effect burden. Pain & inflammation: Uses curcumin (for most people), and Boswellia when curcumin isn't enough. Gut/acid issues: Long-term proton pump inhibitor (PPI) use (e.g., omeprazole, lansoprazole) is flagged as harmful to gut microbiome and nutrient absorption. Curt builds step-down plans (tapering PPIs) while supporting the gut with natural measures instead of leaving people on a PPI for 30 years. Focus on side benefits, not side effects. Green pharmacy interventions are chosen because they: Address root causes (e.g., metabolic health, inflammation, gut integrity). Often have multiple positive effects (e.g., berberine helping blood sugar and lipids; curcumin helping joints and systemic inflammation). The aim is fewer total drugs, fewer side effects, better overall function. Clients are encouraged to work with their doctor, so deprescribing is: Planned, Monitored, and Integrated with their existing care. Curt and Ed both acknowledge there are situations where “rescue medicine” is necessary: Severe pain where an opioid is appropriate. Acute crises where drugs are needed as a bandage. The green pharmacy view: Use those drugs as short‑term tools, Then remove or reduce them once the immediate crisis passes, While implementing natural strategies to decrease the need for long‑term prescriptions. [0:56:26] Final Segment  At‑home HPV testing for cervical cancer Ed explains HPV is a major driver of cervical cancer Historically, women had to schedule an in‑office visit for cervical screening, which creates barriers (cost, fear, time, discomfort, lack of insurance). He notes there is now an option for at‑home HPV testing for cervical screening. Intended to increase access for women who aren't getting regular screening. Ed strongly approves of this as a valuable preventive tool and encourages women who haven't been tested to consider it. Ed cites new data showing: Microplastics are found in 100% of human stool samples tested in one study. Higher levels of microplastics are now being linked to gallstones. Broader concerns: Everyday plastic exposure (especially with food and drink) means these particles can: Interact with cells, Drive inflammation, Contribute to premature cellular aging and reduced energy. Practical countermeasures he recommends: Avoid heating food in plastic or placing hot food into plastic containers/wrap (e.g., Saran wrap, plastic take‑out containers). Filter drinking water to remove microplastics (he's trialing the AquaTru system at home, which he says removes 100% of microplastics and much of the fluoride). Improve indoor air quality to reduce airborne microplastic exposure. Ed highlights a serious, long‑term job opening at Nutrition World: Not a summer or short‑term job. Best for someone philosophically aligned with healthy eating and the “green pharmacy” approach. Interested candidates should: Go into the store and speak with Scott, Elisha, or Matt and complete an application.  The post Radio Show / Podcast – May 31, 2026 first appeared on Vital Health Radio.

Diese Podcast-Folge ist erstmalig am 09.04.2026 im O-Ton Allgemeinmedizin erschienen. Kill the Pill: Deprescribing als wichtige ärztliche Routine Polypharmazie ist im Alter eher die Regel als die Ausnahme. Im Durchschnitt nehmen geriatrische Patientinnen und Patienten neun bis zehn Dauermedikamente ein. Die Risiken werden häufig unterschätzt: Sturzgefahr, Delir, Müdigkeit, sinkende Therapietreue und gefährliche Wechselwirkungen. In dieser Folge von O-Ton Innere Medizin spricht Medizinredakteuer Tobias Stolzenberg mit Prof. Dr. Michael Denkinger, Chefarzt und Ärztlicher Direktor der Agaplesion Bethesda Klinik Ulm und Präsident der Deutschen Gesellschaft für Geriatrie, über das gezielte Reduzieren und Absetzen von Medikamenten, das sogenannte Deprescribing. Prof. Denkinger erklärt, wann Polypharmazie zum Problem wird, welche Rolle Tools wie die FORTA-Liste, die Priscus-Liste und die STOPP/START-Kriterien spielen, und warum klinische Erfahrung, strukturierte Algorithmen und der Dialog mit Patientinnen, Patienten und Angehörigen unersetzlich sind. Außerdem: Wie sieht es haftungsrechtlich aus? Welche Substanzen sind beim Deprescribing besonders heikel – Opioide, Antipsychotika, Schlafmittel? Und was muss sich strukturell ändern, damit Deprescribing in Deutschland Breitenwirkung entfaltet? In dieser Folge u. a.: • Definition und Häufigkeit von Polypharmazie • Drug-Drug- und Drug-Disease-Interaktionen • FORTA, Priscus, STOPP/START, Beers im Vergleich • Deprescribing-Algorithmen und internationale Ressourcen • rechtliche Absicherung und Dokumentation • Wann ist der richtige Zeitpunkt für Deprescribing? • Zukunftsvision: Vernetzung, Digitalisierung, Gesprächsmedizin Gast dieser Folge: Prof. Dr. Michael Denkinger, Agaplesion Bethesda Klinik Ulm; Institut für Geriatrische Forschung am Universitätsklinikum Ulm; Deutsche Gesellschaft für Geriatrie Prof. Denkinger ist Mitglied der FORTA-Expertengruppe. Host dieser Folge: Tobias Stolzenberg, Redakteur bei Medical Tribune in Wiesbaden Weiterführende Links: S3-Leitlinie Hausärztliche Leitlinie Multimedikation https://register.awmf.org/assets/guidelines/053-043l_S3_Multimedikation_2021-08.pdf Priscus 2.0 – Liste potenziell inadäquater Medikation für ältere Menschen https://www.priscus2-0.de/index.html FORTA-Liste – Fit FOR The Aged https://www.umm.uni-heidelberg.de/ecas/experimentelle-pharmakologie/research/gruppe-wehling/ Die FORTA-Liste gibt es auch als App im Google Play Store und im App Store für iPhone. Beers-Kriterien, deutsche Version der Beers-Liste https://www.bcp.fu-berlin.de/pharmazie/faecher/klinische_pharmazie/arbeitsgruppe_kloft/materialien/Beers-Liste.pdf Stopp/Start-Kriterien, in englischer Sprache https://www.cgakit.com/_files/ugd/2a1cfa_94280508e6014f3db06594abd0193994.pdf German Deprescribing Network (GerDeN) https://deprescribing.de Primary Health Tasmania, medication management – deprescribing https://www.primaryhealthtas.com.au/resources/deprescribing-resources/ Deprescribing-Leitlinien und -Empfehlungen Kanada https://deprescribing.org RETREAT-Frail-Studie – Reduction of Antihypertensive Treatment in Nursing Home Residents https://doi.org/10.1056/nejmoa2508157 DANTON-Studie – Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial https://doi.org/10.1093/ageing/afae133 https://bit.ly/3NFotcj

In this episode, Kelly interviews Dr. Mark Horowitz, a psychiatrist and author, about the long-term impacts of antidepressants, the challenges of coming off these medications, and the future of deprescribing. This conversation sheds light on why many people remain trapped on these drugs and what can be done to change this reality. Key Topics: The origins of Dr. Horowitz's involvement in deprescribing and his personal experience The widespread use of antidepressants in America and the long-term health risks How withdrawal symptoms can be mistaken for a need to stay on medication The insidious side effects of antidepressants, including weight gain, sexual dysfunction, and increased risk of fractures The lack of long-term studies and regulatory oversight on the effects of antidepressants The importance of informed consent and alternative treatment options How marketing and legal factors influence prescribing habits Strategies for safe tapering and support resources for deprescribing The evolving awareness and cultural shift regarding antidepressant risks Deprescribing book https://markhorowitz.org/ Listen to my Tedx Talk: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Why we need adult sex ed⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Take my ⁠⁠⁠⁠⁠⁠⁠⁠⁠Adult Sex Ed Master Class:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠My Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Interested in my sexual health and hormone clinic? ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Waitlist is open⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ To learn more about Via vaginal moisturizer from Solv Wellness, visit ⁠⁠⁠⁠⁠via4her.com⁠⁠⁠⁠⁠ and get 20% off your first order. For an additional $5 off, use coupon code DRKELLY5. Clinicians can request patient materials or samples at ⁠⁠⁠⁠⁠hcp.solvwellness.com⁠⁠⁠⁠⁠. Thanks to our sponsor ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Midi Women's Health⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Designed by midlife experts, delivered by experienced clinicians, covered by insurance.Midi is the first virtual care clinic made exclusively for women 40+. Evidence-based treatments. Personalized midlife care.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.joinmidi.com⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices

What if the people case-managing your care had a financial reason to keep you sicker? That's the uncomfortable question Scott Middleton puts on the table in this episode — recorded live from the American Case Managers Conference in Orlando, where Scott went to learn, and ended up being told Your Health didn't "fit" because they weren't a hospital. Jamie and Scott unpack what the nurse case manager role actually looks like at Your Health — and why moving case management out of hospitals and into patients' homes isn't just better care, it's better economics. Scott shares the research proving the model works: 50% reduction in Medicare spend when patients are seen at the right frequency by the right people. In this episode: Why hospitalists may be "the demise of the American healthcare system" The difference between nurse practitioners (diagnose and treat) and nurse case managers (assess and guide) — and why blurring them costs patients The 16.05-visits-per-risk-point model David Clemens' research validated How coding departments are quietly diagnosing patients with diseases they don't have Why Medicare's 6-year insolvency window may be the disruption we need Head-to-toe assessments, delegation rights, and the real job of an RN in the home If you've ever suspected the system is working exactly as designed — just not for the patient — press play. www.YourHealth.Org

What if one of the most “lifelong” medications in medicine… isn't always meant to be lifelong? In this eye-opening episode of the Paloma Health podcast, we unpack the provocative findings of the 2026 RELEASE trial—and the question millions of people over 60 are suddenly asking: Do I still need my thyroid medication? You'll discover why researchers are challenging decades of conventional wisdom, and how a surprising subset of patients may be able to safely reduce—or even stop—treatment under the right conditions.But here's where it gets real: this isn't a story about quitting your meds—it's about personalization. While about 1 in 4 people in the study successfully stopped their medication, the majority still needed it, and many fell somewhere in between—benefiting from lower doses instead. This episode dives into the hidden risks of overtreatment (think heart rhythm issues and bone loss), the gray zone of “borderline” diagnoses, and why aging changes your thyroid needs more than you might expect. It's nuanced, surprising, and deeply relevant if you've ever wondered whether your treatment is still right for you.Most importantly, this conversation empowers you to rethink “autopilot” healthcare. Deprescribing isn't about doing less—it's about doing what's right, right now. You'll learn the critical questions to ask your doctor, the signs your body may still depend on thyroid hormone, and why any changes must be slow, strategic, and medically guided. 

Ahoi! Protonenpumpenhemmer, Pantoprazol, Omeprazol und Co, sind wie „Smarties“ in der täglichen Pharmakotherapie: klein, auch ein wenig bunt, irgendwie toll und nützlich, scheinbar harmlos. Und in rauen Mengen im Umlauf: Allein Pantoprazol kommt 2024 in der GKV auf 23 Millionen Verordnungen, 3 Milliarden Tagesdosen und fast 400 Millionen Euro Nettokosten. Alte Schwedin!

Program notes:0:34 Chronotrope type and timing of exercise1:36 Sedentary adults and morning or evening type2:36 Acting as your own control3:10 Stenting for post thrombotic syndrome4:10 Severity lower with endovascular therapy5:10 Patent in 2/3 at six months6:10 Very diverse patient populations6:28 Estimating kidney function7:28 Currently underestimate compromise8:27 Deprescribing proton pump inhibitors9:27 Three different interventions10:27 Almost 15% achieved outcome in both patient and physician12:08 End

Program notes:0:36 How low should cholesterol be targeted in secondary prevention?1:40 33% reduction with target to 552:36 Able to do it with statin and other drugs3:03 Deprescribing levothyroxine4:06 Were able to discontinue in many 5:05 Thyroid not as responsive with aging6:05 Barriers to deprescribing?6:31 Treatment of HTN in low-income patients7:31 75% unemployed8:31 Patient participates9:06 Manufacturer coupon use10:10 Annual patient use of coupons11:18 Used to drive people to use drugs that are expensive12:33 End

Kill the Pill: Deprescribing als wichtige ärztliche Routine Polypharmazie ist im Alter eher die Regel als die Ausnahme. Im Durchschnitt nehmen geriatrische Patientinnen und Patienten neun bis zehn Dauermedikamente ein. Die Risiken werden häufig unterschätzt: Sturzgefahr, Delir, Müdigkeit, sinkende Therapietreue und gefährliche Wechselwirkungen. In dieser Folge von O-Ton Allgemeinmedizin spricht Medizinredakteuer Tobias Stolzenberg mit Prof. Dr. Michael Denkinger, Chefarzt und Ärztlicher Direktor der Agaplesion Bethesda Klinik Ulm und Präsident der Deutschen Gesellschaft für Geriatrie, über das gezielte Reduzieren und Absetzen von Medikamenten, das sogenannte Deprescribing. Prof. Denkinger erklärt, wann Polypharmazie zum Problem wird, welche Rolle Tools wie die FORTA-Liste, die Priscus-Liste und die STOPP/START-Kriterien spielen, und warum klinische Erfahrung, strukturierte Algorithmen und der Dialog mit Patientinnen, Patienten und Angehörigen unersetzlich sind. Außerdem: Wie sieht es haftungsrechtlich aus? Welche Substanzen sind beim Deprescribing besonders heikel – Opioide, Antipsychotika, Schlafmittel? Und was muss sich strukturell ändern, damit Deprescribing in Deutschland Breitenwirkung entfaltet? In dieser Folge u. a.: • Definition und Häufigkeit von Polypharmazie • Drug-Drug- und Drug-Disease-Interaktionen • FORTA, Priscus, STOPP/START, Beers im Vergleich • Deprescribing-Algorithmen und internationale Ressourcen • rechtliche Absicherung und Dokumentation • Wann ist der richtige Zeitpunkt für Deprescribing? • Zukunftsvision: Vernetzung, Digitalisierung, Gesprächsmedizin Gast dieser Folge: Prof. Dr. Michael Denkinger, Agaplesion Bethesda Klinik Ulm; Institut für Geriatrische Forschung am Universitätsklinikum Ulm; Deutsche Gesellschaft für Geriatrie Prof. Denkinger ist Mitglied der FORTA-Expertengruppe. Host dieser Folge: Tobias Stolzenberg, Redakteur bei Medical Tribune in Wiesbaden Kontakt zur Redaktion: o-ton-allgemeinmedizin@medtrix.group Weiterführende Links: S3-Leitlinie Hausärztliche Leitlinie Multimedikation https://register.awmf.org/assets/guidelines/053-043l_S3_Multimedikation_2021-08.pdf Priscus 2.0 – Liste potenziell inadäquater Medikation für ältere Menschen https://www.priscus2-0.de/index.html FORTA-Liste – Fit FOR The Aged https://www.umm.uni-heidelberg.de/ecas/experimentelle-pharmakologie/research/gruppe-wehling/ Die FORTA-Liste gibt es auch als App im Google Play Store und im App Store für iPhone. Beers-Kriterien, deutsche Version der Beers-Liste https://www.bcp.fu-berlin.de/pharmazie/faecher/klinische_pharmazie/arbeitsgruppe_kloft/materialien/Beers-Liste.pdf Stopp/Start-Kriterien, in englischer Sprache https://www.cgakit.com/_files/ugd/2a1cfa_94280508e6014f3db06594abd0193994.pdf German Deprescribing Network (GerDeN) https://deprescribing.de Primary Health Tasmania, medication management – deprescribing https://www.primaryhealthtas.com.au/resources/deprescribing-resources/ Deprescribing-Leitlinien und -Empfehlungen Kanada https://deprescribing.org RETREAT-Frail-Studie – Reduction of Antihypertensive Treatment in Nursing Home Residents https://doi.org/10.1056/nejmoa2508157 DANTON-Studie – Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial https://doi.org/10.1093/ageing/afae133

Join us as we review and appraise recent practice-changing articles. In this episode, we cover the latest in GLP-1s and GIP agonists for CVD, Type 2 Diabetes, and Obesity, valacyclovir to treat Alzheimer's, weight regain patterns after medication-induced weight loss, and a deep dive into the data behind deprescribing – and behavioral science to increase deprescribing behavior.  Fill your brain hole with a delicious stack of hotcakes! Featuring Paul Williams (@PaulNWilliamz), Alex Chaitoff (@alexchaitoff), Nora Taranto (@norataranto), & Matt Watto (@doctorwatto).Claim CME for this episode at curbsiders.vcuhealth.org!Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CMECredits Written and Hosted by: Nora Taranto MD, MSCE; Alexander Chaitoff MD, MPH; Paul Williams, MD, FACP,, & Matthew Watto MD, FACP Cover Art: Nora Taranto MD, MSCE Reviewer: Sai S Achi MD, MBA, FACP Technical Production: Pod Paste Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Show Segments Intro, disclaimer GLP-1 + GIPs vs GLP-1s for patients with T2DM and Obesity – SURPASS-CVOT  Weight Regain after Weight loss  VALAD – Valacyclovir in patients with early Alzheimer's  Nudges to increase Deprescribing  Outro Sponsor: MedStudy Qbank Study less. Remember more. Pass confidently.Medstudy.com/CurbsidersCURB15 for 15% offSponsor: FIGSWe've teamed up with FIGS, and now Curbsiders listeners can get 15% off at Wearfigs.com with code FIGSRX. Sponsor: QuinceRight now, go to Quince.com/curb for free shipping and 365-day returns. Sponsor: A Dangerous DiagnosisTo get 20% off use DIAGNOSIS20 at www.penguinrandomhouse.com/books/808848/a-dangerous-diagnosis-by-shantanu-rai/paperback/

Dr. Hoffman continues his conversation with Hal Cranmer, co-owner of A Paradise for Parents assisted living homes in Arizona.

Hal Cranmer, co-owner of A Paradise for Parents assisted living homes in Arizona, details improving senior care beyond “warehousing.” Cranmer describes his path from Air Force pilot to assisted living operator and explains changes he implemented over 12 years, emphasizing meaningful exercise (walks, strength training, yoga, multitasking drills) and an “exercise with oxygen therapy” bike. He highlights excessive polypharmacy in seniors and advocates deprescribing, supplement and hormone support when medically ordered, and avoiding sedating drugs used as chemical restraints. Cranmer details a low-glycemic, low-carbohydrate, ketosis-oriented nutrition approach inspired by Dr. Dale Bredesen, reporting significant weight loss and diabetes medication reduction in residents. He discusses COVID practices that preserved family contact and outdoor time, reporting no COVID deaths in his homes, and describes cognitive training via one-on-one Zoom-based brain exercises and personalized memory games.

Philippe Pinel remarked in 1800 that "It is an art of no little importance to administer medicines properly, but it is an art of much greater and more difficult acquisition to know when to suspend or altogether to omit them." This insight remains profoundly relevant today, especially in hospice care, where inappropriate prescribing is a common issue. Studies show that 20%–70% of hospice patients receive at least one unnecessary medication near the end of life, including drugs like antihypertensives, statins, and vitamins. In this episode of the GeriPal Podcast, we tackle the pressing topic of deprescribing at the end of life with expert guests Jennifer Tjia, Jon Furuno, and Simon Mooijaart. The conversation focuses on identifying medications that should almost always be discontinued—such as statins, osteoporosis meds, finasteride, and vitamins, which offer minimal benefit for patients with limited life expectancy. We also delve into more nuanced cases, such as antithrombotics, which present complex decisions that challenge clinicians, particularly when prognosis spans the many weeks to months range. Finally, we explore practical strategies for engaging patients and families in deprescribing conversations. Our guests highlight tools such as the FRAME mnemonic (Focus on the goals of care, Review current medications, Assess each medication's risk/benefit, Minimize the medication burden, and Evaluate regularly) and the Goal Concurrent Prescribing tool, which helps ensure medication decisions align with patients' values and end-of-life priorities. By: Eric Widera Other resources discussed in the podcast Prevalence and Factors Associated With Receiving a Prescription for Antithrombotic Therapy on Hospice Admission," JAGS. 2025 Discontinuation of Anticoagulants and Occurrence of Bleeding and Thromboembolic Events in Vitamin K Antagonist Users with a Life-limiting Disease. 2025 Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial. 2024 Perspectives on deprescribing in palliative care. Expert Review of Clinical Pharmacology. 2023 Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study. Thrombosis Research. 2025 Human-Centered Design Development and Acceptability Testing of a Goal Concordant Prescribing Program in Hospice. JPM 2025 Reduction of Antihypertensive Treatment in Nursing Home Residents. NEJM 2025  

Are you on medications you're not sure you still need, but too afraid to stop?In this episode of The Balanced Body Podcast, I'm joined by Stacey D'Angelo, pharmacist specializing in deprescribing and pharmacogenetics. We're diving into what it really means to safely reduce medications like antidepressants, anti-anxiety drugs, PPIs (acid reflux medications), and hormonal birth control — and why tapering properly matters more than most people realize.We also unpack pharmacogenetics (PGx) — a DNA-based test that predicts how your body responds to medications. This personalized approach can reduce the frustrating trial-and-error many women experience, especially with mental health prescriptions.If you've ever wondered:“Do I still need this medication?”“Why do I feel worse when I try to come off?”“Is there a safer, more personalized way to approach my health?”This conversation will open your eyes.Connect with Stacey:Instagram: https://www.instagram.com/yoursimplehealthLinkedIn: Your Simple Health, Stacey D'AngeloWebsite: www.simplehealthpharmacist.comThanks for listening. Please rate & review so we can reach more women with this very important information. Share with a friend whom you know would benefit from listening to The Balanced Body Podcast.Follow your host, Monika Eva, on IG here: https://www.instagram.com/monikaeevaTake my FREE Weight Loss & Energy Blocker Assessment to find out what's blocking you from releasing the weight & being energized here:https://www.monikaeva.com/whatsblockingyouLearn more about working with Monika here:https://www.monikaeva.com

Editor's Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from January 24-30, 2026.

Klinisch Relevant ist Dein Wissenspartner für das Gesundheitswesen. Drei mal pro Woche, nämlich dienstags, donnerstags und samstags, versorgen wir Dich mit unserem Podcast und liefern Dir Fachwissen für Deine klinische Praxis. Weitere Infos findest Du unter https://klinisch-relevant.de

In this podcast accompanying the September issue of DTB (https://dtb.bmj.com/content/63/9), David Phizackerley (DTB Editor) is joined by Syba Sunny (DTB Clinical Editor). David and Syba discuss the editorial that highlights changes to antibiotic susceptibility reports, and in particular, the change to the 'I' classification from 'intermediate' to 'susceptible, increased exposure' (https://dtb.bmj.com/content/63/9/130). They talk about a DTB Select article that summarises an evidence review of deprescribing interventions in primary care and the importance of collaborative multidisciplinary teams, education and training, and shared-decision making (https://dtb.bmj.com/content/63/9/131). They finish by discussing the main article that provides an overview of pharmacological management of chronic heart failure with reduced ejection fraction and the four main groups of drugs that form the four pillars of treatment (https://dtb.bmj.com/content/63/9/133).   Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page. If you want to contact us please email dtb@bmj.com. Thank you for listening.

In this episode of the Astonishing Healthcare podcast, host Justin Venneri sits down with Lauren Carroll, PharmD, a Senior Clinical Programs Manager at Capital Rx, to discuss Rx Retro, a pharmacist-led program that focuses on medication deprescribing to enhance patient safety, reduce adverse drug events, and improve healthcare outcomes. Lauren shares insights into how Rx Retro leverages Judi® - Capital Rx's enterprise health platform - to identify and address drug therapy concerns through a series of alerts and outreach designed to promote the safest and most effective treatments for plan members. The conversation also highlights the broader implications of deprescribing for healthcare quality and cost savings, with Lauren noting that, "We are uniquely positioned to bridge gaps that exist in the healthcare system."HighlightsDeprescribing Defined: The process of discontinuing potentially inappropriate medications under a healthcare provider's supervision.Judi® identifies drug therapy concerns in real-time, even across multiple prescribers and pharmacies.Rx Retro's Two Levels: Level 1 involves fax notifications to prescribers, while Level 2 includes direct pharmacist outreach and patient counseling.Broader Impact: Rx Retro addresses clinical areas like polypharmacy, duplication of therapy, and high-risk medications in vulnerable populations, and can help with quality metrics and scores that impact plans' star ratings.Related Content:AH035 - Pharmacy Benefits 101: Clinical Programs, with Bonnie Hui-Callahan, PharmDPharmacy Benefits 101: Building an Award-Winning Call Center from ScratchAH006 - Pharmacy Benefits 101: Clinical Care Teams, with Amy Stockton, PharmDPharmacy Benefits 101: What's the Drug Management Program (DMP)?AH073 - How Low Cost Alternative Programs Can & Should Work, with Jackie Lolos, PharmD, and Haleh Campbell, PharmDFor more information about Capital Rx and this episode, please visit Capital Rx Insights.

Broadcast from KSQD, Santa Cruz on 7-03-2025: Dr. Dawn responds to an email about vitamin D and statin interactions, explaining how statins may prevent vitamin D's longevity benefits by interfering with CoQ10 production. She references a study showing vitamin D preserved telomeres and prevented aging over 3-4 years, but benefits disappeared in statin users. For borderline high LDL, she recommends testing for large versus small particles and oxidized LDL rather than treating with statins or red yeast rice. Red yeast rice may also block CoQ10 production, potentially negating vitamin D benefits. She discusses the critical problem of overmedication in elderly patients through a story of a 75-year-old taking 21 prescription drugs who improved dramatically when reduced to eight medications. Multiple specialists practicing standard care in isolation create dangerous polypharmacy without coordination. HIPAA privacy laws prevent medication sharing between providers, while electronic medical records remain siloed and incompatible. England's pilot program will provide whole genome screening for every newborn within 10 years, assessing hundreds of disease risks and enabling personalized medicine. While beneficial for identifying genetic disorders and drug metabolism variations like 2D6 mutations affecting tamoxifen effectiveness, Dr. Dawn expresses concern about government surveillance implications. Unlike voluntary phone tracking, this represents involuntary comprehensive genetic monitoring of citizens unable to provide informed consent. She describes alarming research showing cancer cells steal mitochondria from nerve cells by extending tubes and sucking out energy-producing organelles. This behavior helps cancer cells survive the hostile journey through bloodstream during metastasis. Turbocharged cancer cells with stolen mitochondria generate more energy and survive better when subjected to physical stress mimicking bloodstream travel. Dr. Dawn explores the parasitic amoeba Entamoeba histolytica, which causes intestinal disease but can become invasive, liquefying organs through tissue destruction. The parasite kills cells without eating them immediately, then consumes fragments and displays stolen cellular proteins on its surface to fool the immune system, potentially leading to CRISPR-based treatments or targeted drugs. She discusses converting plastic waste into acetaminophen using modified E. coli bacteria. Researchers chemically degrade PET plastic into precursor molecules, then use bacterial enzymes to complete synthesis into paracetamol with 92% efficiency. This transforms environmental waste into globally important medication, though she notes acetaminophen risks for regular drinkers due to toxic liver metabolites. MIT research reveals that AI writing assistance reduces brain engagement, memory, and sense of authorship. Students using ChatGPT showed lower neural connectivity in memory, attention, and executive function networks over four months. AI users retained less information and struggled to quote from their own essays. Dr. Dawn compares this to physical atrophy, emphasizing that cognitive challenge strengthens neural pathways like exercise strengthens muscles. She warns about fluoroquinolone antibiotics causing aortic aneurysm ruptures, in addition to known risks of tendon ruptures and retinal detachment. People with dilated aortas, hypertension history, or smoking should avoid these drugs entirely. This represents new information that wasn't widely known among primary care physicians, highlighting the importance of continuing medical education. Research shows celecoxib (Celebrex) cuts colon cancer recurrence rates in half for patients with circulating tumor DNA, but provides no benefit without detectable residual disease. This anti-inflammatory drug appears to impair cancer's ability to thrive in metastatic conditions. The finding supports using circulating tumor DNA testing to identify who needs targeted therapy rather than treating everyone. Dr. Dawn concludes with surprising research showing chronic inflammation during aging occurs only in industrialized societies. Studies comparing indigenous communities from Bolivian Amazon and Malaysia with populations from Italy and Singapore found inflammatory cytokines increase with age only in industrialized groups.

In this episode, we discuss evidence-based strategies for safely tapering patients off benzodiazepines, including cut-and-hold and microtapering techniques. What's the best approach when commercial dosage forms limit gradual reductions? Faculty: Alexis Ritvo Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CME: Strategies for Successful Benzodiazepine Deprescribing Techniques for Successful Benzodiazepine Tapering

Polymedikation im Blick: Sicher absetzen mit System

Dr Anirudh Kumar, Geriatric Medicine Registrar, demystifies resources and tools to aid evidence-based deprescribing decisions, particularly for older people.We recommend considering listening to the following other podcast episodes to supplement this episode:Episode 226 - Anticholinergic BurdenPodomatic Apple Podcasts SpotifyFollow us on Instagram!Join our Discord server or follow our podcast via our Linktree!

In this episode, we explore the complex process of benzodiazepine deprescribing, examining when and how to help patients reduce or discontinue these medications. How can clinicians balance the benefits of deprescription against the challenges of withdrawal? Faculty: Alexis Ritvo, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 1.25 CMEs: Strategies for Successful Benzodiazepine Deprescribing Benzodiazepine Deprescription: Indications, Benefits, and Risks

D is for deprescribing! Jody wrestles with this very complicated and grey area of medical practice.Resources:Beers Criteria (AGS)STOPP/START CriteriaDeprescribing.orgMedStopperNO TEARSNICE Medicines Optimization GuidelinesEMPOWER BrochuresThe list of deprescribing resources was generated by ChatGPT.

Send us your questions for Fishbowl 6!Here Dr. H sits down with Lisa, a pediatric nurse practitioner, to witness her story of developmental trauma, concomitant chronic depression, and eventually her path of healing and rebuilding trust and connection, largely through psychotherapy.  During her years of intermittently crippling and suicidal depression, she was put on various psych meds, which might have helped at the time, but later became shockingly difficult to try to taper and stop. This is a story of overcoming shame, a story that looks at the question of whether people need meds for life….and it turns out, surprise surprise, that what's causing or driving depression actually really matters….and when that's a Mom wound, most psych meds are really just acting as flimsy bandages."I Love You, I Hate You, Are You My Mom?"  An intensive experiential workshop exploring transference with Dr. H and Dr. Hillary McBride, May 28-30 in Victoria BChttps://www.eventbrite.com/e/i-love-you-i-hate-you-are-you-my-mom-tickets-1112117516429?aff=ebdssbdestsearchBFTA on IG @backfromtheabysspodcasthttps://www.instagram.com/backfromtheabysspodcast/BFTA/ Dr. Hhttps://www.craigheacockmd.com/podcast-page/

Send BFTA a commentDr. H breaks down the complex task of deprescribing into six clear steps, starting with the most important and challenging question of all:   Who is the patient and why are they suffering?"Bringing Therapy into Med Management"-- a psychotherapy training intensive with Dr. H for psych NPs and PAs this October in Ft Collins https://www.craigheacockmd.com/training/BFTA on IG @backfromtheabysspodcasthttps://www.instagram.com/backfromtheabysspodcast/BFTA/ Dr. Hhttps://www.craigheacockmd.com/podcast-page/

Join Dr. Andy Cutler as he talks with Dr. Jeffrey Strawn about how clinicians can determine the appropriate scenarios for benzodiazepine deprescribing, best practices for benzodiazepine tapering, and how to balance patient preferences to ensure best outcomes.  Jeffrey R. Strawn, MD is a Professor and Associate Vice Chair of Research in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati (UC) College of Medicine, the Assistant Director of Clinical and Translational Research in the Center for Clinical & Translational Science and Training at UC, and an Associate Professor in the Department of Pediatrics at UC and Cincinnati Children's Hospital Medical Center.   Andrew J. Cutler, MD is a distinguished psychiatrist and researcher with extensive experience in clinical trials and psychopharmacology. He currently serves as the Chief Medical Officer of Neuroscience Education Institute and holds the position of Clinical Associate Professor of Psychiatry at SUNY Upstate Medical University in Syracuse, New York.  Save $100 on registration for 2025 NEI Spring Congress with code NEIPOD25  Register today at nei.global/spcongress25p  Never miss an episode!

Dr. Jennifer Giordano, widely recognized as Dr. G, is a psychiatrist who uses a holistic approach to help those who want to take an active role in their health and avoid, decrease, or stop using psychiatric medications.  She saw the major gap in the medical community in the understanding of psych med tapering and wanted to help fill it, which grew into working one-on-one with hundreds of people to safely and successfully navigate the tapering terrain. SHOWNOTES:

It's another deprescribing super special on today's GeriPal Podcast, where we delve into the latest research on deprescribing medications prescribed to older adults. Today, we explore four fascinating studies highlighting innovative approaches to reducing medication use and improving patient outcomes. In our first segment, we discuss a study led by Constance Fung and her team, which investigated the use of a masked tapering method combined with augmented cognitive behavioral therapy for insomnia (CBTI) to help patients discontinue benzodiazepines. The study involved 188 middle-aged and older adults who had been using medications like lorazepam, alprazolam, clonazepam, temazepam, and zolpidem for insomnia. The results were impressive: 73% of participants in the masked tapering plus augmented CBTI group successfully discontinued their medication, compared to 59% in the open taper plus standard CBTI group. This significant difference highlights the potential of targeting placebo effect mechanisms to enhance deprescribing efforts. Next, we turn to Emily McDonald, the director of the Canadian Medication Appropriateness and Deprescribing Network, to discuss her study on the impact of direct-to-consumer educational brochures on gabapentin deprescribing. Patients received brochures detailing the risks of gabapentinoids, nonpharmacologic alternatives, and a proposed deprescribing regimen (see here for the brochure). Additionally, clinicians participated in monthly educational sessions. The intervention group saw a deprescribing rate of 21.1%, compared to 9.9% in the usual care group. This study underscores the power of patient education in promoting safer medication use. In our third segment, we explore Amy Linsky's study that examined the effect of patient-directed educational materials on clinician deprescribing of potentially low-benefit or high-risk medications, such as proton pump inhibitors, high-dose gabapentin, or risky diabetes medications. The intervention involved mailing medication-specific brochures to patients before their primary care appointments (click here for the brochure). The results showed a modest but significant increase in deprescribing rates among the intervention group. This approach demonstrates the potential of simple, low-cost interventions to improve medication safety. Finally, we discuss Michelle Odden's study, which used a target trial emulation approach to investigate the effects of deprescribing antihypertensive medications on cognitive function in nursing home residents. The study included 12,644 residents and found that deprescribing was associated with less cognitive decline, particularly among those with dementia4. These findings and the two studies Michelle mentions in the podcast (DANTE and OPTIMIZE) suggest that carefully reducing medication use in older adults may help preserve cognitive function. However, the DANTON study adds more questions to that conclusion. Join us as we dive deeper into these studies and discuss the implications for clinical practice and patient care. Don't miss this episode if you're interested in the latest advancements in deprescribing research!

This episode of the Geriatric Pharmacy Focus discusses medications and supplements to deprescribe along with deprescribing resources.  Dr. DeLon shares insights into how to monetize deprescribing.  We end with gratitude and goals as we head into a new year! Dr. Tamara Ruggles:  www.linkedin.com/in/tamara-ruggles-491882251 Dr. DeLon Canterbury:  www.linkedin.com/in/geriatrx/

James Greenblatt, MD, joins Integrative Practitioner Content Specialist Avery St. Onge to discuss how to use integrative and functional medicine strategies to properly wean patients off antidepressants while avoiding withdrawal symptoms. This episode is brought to you by the Integrative Healthcare Symposium. Register for the Symposium and receive 15% off with promo code IP2025PODCAST: https://xpressreg.net/register/ihsy0225/landing.php?sc=IP2025PODCAST Learn more about the event by visiting the Symposium website: www.ihsymposium.com Contact the Integrative Healthcare Symposium team: info@ihsymposium.com Find us at integrativepractitioner.com or e-mail us at IPEditor@divcom.com. Theme music: "Upbeat Party" by Scott Holmes via freemusicarchive.org, "Carefree" by Kevin Mcleod via incompetech.com, and “Relaxing Light Background” by AudioCoffee. About the Expert A pioneer in the field of Functional, Nutritional, & Metabolic Psychiatry, dually board-certified Adult and Child & Adolescent psychiatrist Dr. James M. Greenblatt has been treating patients since 1988. After obtaining his medical degree and completing his psychiatry residency at George Washington University, Dr. Greenblatt completed a fellowship in Child & Adolescent psychiatry at Johns Hopkins Medical School. He has served as Chief Medical Officer at Walden Behavioral Care in Waltham, MA for nearly 22 years, and is a member of the clinical psychiatry faculty at the Tufts University School of Medicine and the Dartmouth College Geisel School of Medicine.  Dr. Greenblatt is the author of eight books, including the bestselling Finally Focused and the expert-acclaimed Answers to Anorexia (2021). His newest book, Functional & Integrative Medicine for Antidepressant Withdrawal, is available now.  A nationally and internationally recognized expert, author, and educator, as well as an inductee of the ISOM Orthomolecular Medicine Hall of Fame, Dr. Greenblatt is also the founder of Psychiatry Redefined – an online Continuing Medical Education platform dedicated to the advancement of evidence-based, personalized treatment models for mental illness.

Dr. Bret Scher interviews Dr. Josef Witt-Doerring, a board-certified psychiatrist who specializes in tapering and deprescribing psychiatric medications. Dr. Josef combines his expertise in pharmaceutical safety, clinical psychiatry, and metabolic therapies to help patients safely transition off long-term medications. Topics Covered Life-Changing Outcomes Discover how Dr. Josef's holistic methods have empowered individuals like Trudy, who transitioned from years of debilitating medications to pursuing a career in medical school through targeted dietary and metabolic interventions. Rethinking Psychiatric Medications Dr. Josef discusses the complex nature of antidepressants, antipsychotics, and mood stabilizers. Learn how their effects can mask symptoms without addressing root causes and the challenges of long-term use, including tolerance, side effects, and withdrawal. The Role of Metabolic Therapies Hear about the surprising success stories of patients who used dietary changes like ketogenic or gluten-free diets to overcome severe mental health conditions, reduce medication reliance, and regain their quality of life. Deprescribing in Practice Dr. Josef shares his patient-led approach to tapering medications, including practical tips on dosage reduction, liquid formulations, and the importance of balancing withdrawal risks with ongoing medication effects. Dr. Josef's message challenges conventional psychiatry by prioritizing patient-centered care and exploring innovative therapies that focus on the root causes of mental health challenges. This conversation provides hope and practical insights for individuals and clinicians navigating the complexities of psychiatric medication. Experts Featured Dr. Josef Witt-Doerring Taper Clinic https://taperclinic.com/dr-josef-witt-doerring/ X: @taperclinic Instagram: https://www.instagram.com/taperclinic/ Follow our channel for more information and education from Bret Scher, MD, FACC, including interviews with leading experts in Metabolic Psychiatry. Learn more about metabolic psychiatry and find helpful resources at https://metabolicmind.org/ About us: Metabolic Mind is a non-profit initiative of Baszucki Group working to transform the study and treatment of mental disorders by exploring the connection between metabolism and brain health. We leverage the science of metabolic psychiatry and personal stories to offer education, community, and hope to people struggling with mental health challenges and those who care for them. Our channel is for informational purposes only. We are not providing individual or group medical or healthcare advice nor establishing a provider-patient relationship. Many of the interventions we discuss can have dramatic or potentially dangerous effects if done without proper supervision. Consult your healthcare provider before changing your lifestyle or medications. #MetabolicMind #MetabolicNeuroscience #MetabolicPsychiatry#KetogenicMetabolicTherapy #KetogenicTherapy#KetoForMentalHealth#Keto#TaperingMedications #Deprescribing

This episode discusses the relevancy of the Beers Criteria in clinical practice, examining how recent changes impact medication safety and prescribing practices for older adults. Learn strategies for effective deprescribing and discover best practices for applying these criteria to improve patient outcomes. This essential episode equips healthcare professionals with the knowledge needed to navigate complex medication regimens and advocate for safer prescribing practices. HOSTJoshua Davis Kinsey, PharmDVP, EducationCEimpactGUESTKristin Meyer, PharmD, BCGP, FASCPProfessor of Pharmacy PracticeDrake University College of Pharmacy and Health SciencesREFERENCEAmerican Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medication use in older adultsPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss recent updates to the Beers Criteria and their impact on medication safety for older adults.2. Describe evidence-based strategies to implement the Beers Criteria and manage complex medication regimens in clinical practice.0.05 CEU/0.5 HrUAN: 0107-0000-24-282-H01-PInitial release date: 10/28/2024Expiration date: 10/28/2025Additional CPE details can be found here.Looking for more? Check out our course on deprescribing in older adults: Less is More: A Patient-Centered Approach to Deprescribing for Older Adults1 hour  |  On DemandPolypharmacy in older adults leads to significant health risks and increased costs. Learn how to effectively engage in deprescribing, using patient-centered and evidence-based approaches to reduce unnecessary medications. Enroll in this course to enhance your skills in facilitating safer medication practices, become a leader in deprescribing, and improve patient outcomes!

In the first episode of a special pediatric psychopharmacology series hosted by Dr. Jeffrey Strawn, Dr. John Walkup joins the podcast to discuss deprescribing in pediatric patients. The conversation delves into the situations that warrant deprescribing from antidepressants, selecting the right time to do so, and dealing with relapse, as well as much more!  Jeffrey R. Strawn, MD is a Professor and Associate Vice Chair of Research in the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati (UC) College of Medicine, the Assistant Director of Clinical and Translational Research in the Center for Clinical & Translational Science and Training at UC, and an Associate Professor in the Department of Pediatrics at UC and Cincinnati Children's Hospital Medical Center.  John T. Walkup, MD is Head of the Pritzker Department of Psychiatry and Behavioral Health at Ann & Robert H. Lurie Children's Hospital of Chicago and a Margaret C. Osterman Professor of Psychiatry and Behavioral Science. He also serves as Director of the Division of Child and Adolescent Psychiatry in the Department of Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine.  Never miss an episode!

An alarming number of individuals find themselves dependent on antidepressants and psychiatric medications, desperately seeking guidance on how to safely discontinue their use. The general medical community has failed to assist people in safely getting off these drugs. The dependency can create severe withdrawal symptoms. Most doctors have no clue how to get their patients off safely keeping them in a cycle of drug dependency. The worst of prescribers will frame the withdrawal symptoms as worsening "depression" and justification for staying on drugs. On Episode 154 of the Radically Genuine Podcast Dr. Roger McFillin dives into the topic of deprescribing and tapering off psychiatric drugs with a pharmacist. Dr. Shawn Gill, PharmD, is a pharmacist, writer, podcaster, and entrepreneur dedicated to sparking change in healthcare through deprescribing. He is the founder of Deprescribe Solutions, an independent consulting practice focused on reversing early-stage chronic conditions in mental health, hypertension, and type 2 diabetes. He hosts the "Deprescribe" podcast and writes the Substack newsletter "B.U.D.S," where he explores topics in health, deprescribing, parenting, and personal growth. Chapters00:00 The Silent Epidemic of Over-Prescription03:06 The Role of Pharmacists in Mental Health06:11 Understanding Compounding Pharmacy09:01 Polypharmacy: A Growing Concern11:58 The Dangers of SSRIs and SNRIs15:12 The Ethics of Prescribing Practices18:01 Navigating Withdrawal and Tapering20:57 Hyperbolic vs. Linear Tapering24:14 Protracted Withdrawal: Understanding the Risks26:49 Preventing Dependency: Education and Awareness29:58 The Future of Mental Health TreatmentResources: Systematic review detailing the relationship between SERT occupancy and SSRI dosing.- This is a great systematic review that breaks down the hyperbolic nature of SSRIs. It also elucidates on the potential pharmacology and mechanism behind protracted withdrawal, which we touched upon. RELEASE Clinical Trial - RCT which will be investigating hyperbolic tapering vs. linear tapering. The trial will begin in 2025.Outro Health - Fantastic organization trying to scale and make hyperbolic tapering accessible to the US. Dr. Sean Gill SubstackDeprescribe Podcast w/ Dr. Sean Gill RADICALLY GENUINE PODCASTDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here—-----------FREE DOWNLOAD! DISTRESS TOLERANCE SKILLS

With the upcoming implementation of the new CMS age-friendly hospital measure, hospitals will be required to attest that they review medications to identify potentially inappropriate medications (PIMS) for older adults. Dr. Martin Casey, MD, MPH is an Assistant Professor in the Department of Emergency Medicine at UNC School of Medicine. Dr. Caseys' work has focused on the identifying PIMS and finding opportunities to reduce the use of, and deprescribe, potentially harmful medications in the emergency department. In this episode, Dr. Christina Shenvi and Dr. Martin Casey will discuss strategies for ED physicians who face unique challenges when assessing older patients' medications. Using case examples of deprescribing in practice, they illustrate how deprescribing is a nuanced skill and how to approach it.

In this interview for MIA Radio, Brooke Siem speaks with David Taylor and Mark Horowitz about their publication of the Maudsley Deprescribing Guidelines, which is of particular note since the Maudsley Prescribing Guidelines is a leading text in medicine worldwide. David Taylor is the Director of Pharmacy and Pathology at Maudsley Hospital and a Professor of Psychopharmacology at King's College in London. He is also the editor-in-chief of the journal Therapeutic Advances in Psychopharmacology. Beyond academia, he contributes significantly to public health policy as a member of the United Kingdom's Department of Transport expert panel that introduced drug-driving regulations. He is also a current member of the UK government's Advisory Council on the Misuse of Drugs and is the only pharmacist to have been made an honorary fellow of the Royal College of Psychiatrists. David is the lead author of the Maudsley Prescribing Guidelines, a role he has held since their inception in 1993. The Maudsley Prescribing Guidelines have achieved significant success, with over 300,000 copies sold across 14 editions and translations into 12 languages. David has also authored 450 clinical papers published in prominent journals such as The Lancet, BMJ, British Journal of Psychiatry, and Journal of Clinical Psychiatry. His work has been cited over 25,000 times. Mark Horowitz is a clinical research fellow in psychiatry at the National Health Service (NHS) in London. He is a Visiting Lecturer in Psychopharmacology at King's College London and an Honorary Clinical Research Fellow at University College London, in addition to being a trainee psychiatrist. Mark holds a PhD from the Institute of Psychiatry, Psychology, and Neuroscience at King's College London, specializing in the neurobiology of depression and antidepressant action. He is the lead author of the Maudsley Deprescribing Guidelines and an associate editor of Therapeutic Advances in Psychopharmacology. Mark co-authored the recent Royal College of Psychiatry's guidance on stopping antidepressants, and his work has informed the recent NICE guidelines on the safe tapering of psychiatric medications, including antidepressants, benzodiazepines, and z-drugs. He has collaborated with the NHS to develop national guidance for safe deprescribing for clinicians and has been commissioned by Health Education England to prepare a teaching module on how to safely stop antidepressants. Mark has published several papers on safe approaches to tapering psychiatric medications, with contributions in The Lancet Psychiatry, JAMA Psychiatry, and Schizophrenia Bulletin. His interest lies in rational psychopharmacology and the deprescribing of psychiatric medications, which is deeply informed by his personal experiences of the challenges associated with coming off psychiatric medications. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2024. Produced by James Moore https://www.jmaudio.org

In this episode, we discuss the approach to deprescribing for several drugs such as benzodiazepine receptor agonists, cholinesterase inhibitors, memantine, antipsychotics, and antihyperglycemics. Key Concepts Medication appropriateness including indication and risk vs. benefit should be evaluated for all stages of life; however, more importantly in older individuals to address polypharmacy. There is an emerging trend of deprescribing networks that conduct research and provide evidence-based recommendations for how to deprescribe certain medications used for specific indications. Evidence-based deprescribing guidelines for PPIs, benzodiazepines, benzodiazepine receptor agonists, opioids, antipsychotics, cholinesterase inhibitors, memantine, and antihyperglycemics are available for patient-provider shared decision making.  A general deprescribing approach is gradual tapering of the drug leading to discontinuation over several weeks while monitoring patients for withdrawal symptoms or benefits of discontinuation.  References http://deprescribing.org https://www.australiandeprescribingnetwork.com.au

About this episode: One in five U.S. adults is taking five or more prescription drugs at a time, often for years without reassessment of need, dosage, or possible interactions. Today, a look at polypharmacy and why it's important for physicians to periodically check in with patients about all the prescription—and nonprescription—drugs they're taking. The guests also discuss the importance of considering non-pharmaceutical treatments like physical or talk therapy, and empowering patients and their care partners to ask questions about what they're being prescribed. Guests: Dr. Cynthia Boyd is a geriatrician and faculty at Johns Hopkins Medicine. She is also a senior associate with the Johns Hopkins Center on Aging and Health. Dr. Ariel Green is a geriatrician and faculty at Johns Hopkins Medicine. She is also a core faculty member of the Johns Hopkins Bloomberg School of Public Health Center for Drug Safety and Effectiveness. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs, the largest center at the Johns Hopkins Bloomberg School of Public Health. Show links and related content: Taking Multiple Medications? You May Need to Scale Back.—The New York Times Taking more than 5 pills in a day? ‘Deprescribing' can prevent harm—especially for older people—The Conversation Contact us: Have a question about something you heard? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on X @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed

Dr. Hoffman continues his conversation with Dr. Mark Horowitz, co-author of "The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs."

All sorts of medications are prescribed for anxiety in older adults. Today, we look at when and how to discontinue them.CME: Take the CME Post-Test for this EpisodePublished On: 03/25/2024Duration: 22 minutes, 47 secondChris Aiken, MD, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Join Shawn and friends this spring for an all-inclusive intimate cabin retreat in the beautiful Smokey Mountains of Tennessee. Two dates to choose from. Use code CARNIVOREDIET to get your discount. Go to https://wired4healing.com/retreats/ to sign up before tickets run out! Timestamps: 00:00 Introductions. 05:29 Scott, former fitness business owner, finds new interest in carnivore. 07:03 Educational farm tour, focus on wellness and fun. 12:53 Health professionals and fitness instructors. 15:38 Carnivore diet healing properties. 17:16 Carnivore diet research. 21:19 A high-fat diet for diabetics. 24:50 Not all carbs are harmful, but some are. 28:14 People's health and exercise routines are individual. 31:26 Deprescribing medications. 34:42 Community connection. 38:56 Carnivore diet health benefits. 40:54 How to visit. See open positions at Revero: https://jobs.lever.co/Revero/ Join Carnivore Diet for a free 30 day trial: https://carnivore.diet/join/ Carnivore Shirts: https://merch.carnivore.diet Subscribe to our Newsletter: https://carnivore.diet/subscribe/ . ‪#revero #shawnbaker #Carnivorediet #MeatHeals #HealthCreation   #humanfood #AnimalBased #ZeroCarb #DietCoach  #FatAdapted #Carnivore #sugarfree  ‪